Palisade Bio (PALI) Cash from Investing Activities (QoQ) (2010 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -200.00% |
| Mar 31, 2018 | 1,225,590.20% |
| Dec 31, 2017 | -114.74% |
| Jun 30, 2016 | -101.35% |
| Mar 31, 2016 | 393.27% |
| Dec 31, 2015 | -125.56% |
| Sep 30, 2015 | 10,852.44% |
| Jun 30, 2015 | 5.45% |
| Mar 31, 2015 | -29.24% |
| Dec 31, 2014 | 20.03% |
| Sep 30, 2014 | 43.91% |
| Jun 30, 2014 | 98.89% |
| Mar 31, 2014 | -16,387.95% |
| Dec 31, 2013 | 55.42% |
| Sep 30, 2013 | -47.11% |
| Jun 30, 2013 | -45.42% |
| Mar 31, 2013 | -45.50% |
| Dec 31, 2012 | -72.27% |
| Sep 30, 2012 | 68.06% |
| Jun 30, 2012 | -320.34% |
| Mar 31, 2012 | 52.68% |
| Dec 31, 2011 | 54.10% |
| Sep 30, 2011 | 31.36% |
| Jun 30, 2011 | -103.76% |
| Mar 31, 2011 | 24.73% |
| Dec 31, 2010 | -42.94% |